Non-Small-Cell Lung Cancer
Showing 1 - 25 of 120
Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)
Recruiting
- Non-small-cell Lung Cancer
- TQB2450 +Anlotinib+Docetaxel
- TQB2450 +Androtinib Placebo+Docetaxel
-
Huizhou, Guangdong, China
- +4 more
Nov 15, 2023
Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)
Recruiting
- Non-Small-Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 25, 2023
Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)
Not yet recruiting
- Non-small-cell Lung Cancer
- (no location specified)
Jun 8, 2023
Non-small-cell Lung Cancer Trial in Rome (Fitbit charge)
Recruiting
- Non-small-cell Lung Cancer
- Fitbit charge
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Apr 4, 2023
Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)
Active, not recruiting
- Advanced Malignancies
- Non-small-cell Lung Cancer
-
Beijing, Beijing, China
- +51 more
Jan 11, 2023
Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)
Active, not recruiting
- Renal Cell Cancer
- +9 more
- PF-07263689
- Sasanlimab
-
Duarte, California
- +5 more
Nov 8, 2022
Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))
Recruiting
- Non-Small-Cell Lung Cancer
- Recombinant human endostatin (Endostar)
-
Jinan, Shandong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022
Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States
Active, not recruiting
- Non-small-cell Lung Cancer
- +5 more
- PF-07209960
-
Duarte, California
- +11 more
Oct 10, 2022
Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)
Recruiting
- Advanced Cancer
- +7 more
-
Scottsdale, Arizona
- +14 more
Sep 15, 2022
Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)
Recruiting
- Clear Cell Renal Cell Cancer
- +8 more
- AZD8701
- Durvalumab
-
La Jolla, California
- +22 more
Aug 12, 2022
Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib (160mg))
Recruiting
- Non-Small-Cell Lung Cancer
- Furmonertinib (160mg)
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 2, 2022
Atezolizumab in Unresectable, Locally Advanced or Metastatic
Completed
- Non-small-Cell Lung Cancer
-
Akashi, Japan
- +197 more
Jul 20, 2022
Non-Small-Cell Lung Cancer Trial in Hong Kong, Taiwan, United States (CAB-AXL-ADC, PD-1 inhibitor)
Recruiting
- Non-Small-Cell Lung Cancer
- CAB-AXL-ADC
- PD-1 inhibitor
-
Duarte, California
- +34 more
Jul 11, 2022
Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer Trial in Worldwide
Recruiting
- Cervical Cancer
- +4 more
-
La Jolla, California
- +19 more
Jun 28, 2022
Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)
Recruiting
- Non-Small-Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Apr 20, 2022
Non-small-cell Lung Cancer Trial (Functional Imaging of Treatment Effects)
Completed
- Non-small-cell Lung Cancer
- Functional Imaging of Treatment Effects
- (no location specified)
Jan 28, 2022
Non-Small-Cell Lung Cancer Trial in China (SHR-1316?Paclitaxel (Albumin Bound)?Carboplatin, SHR-1316?Chemotherapeutic,
Recruiting
- Non-Small-Cell Lung Cancer
- SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin
- +2 more
-
Beijing, Beijing, China
- +6 more
Oct 27, 2021
Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib, Anlotinib)
Recruiting
- Non-Small-Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Oct 14, 2021
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung
Completed
- Non-small-cell Lung Cancer
- +2 more
- DNA sequencing
-
Aalborg, DenmarkDept. of Oncology, Aalborg University Hospital
Aug 3, 2021
Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma Trial in Shanghai (SG001)
Recruiting
- Advanced Solid Tumours
- +4 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Apr 29, 2021